Renal Cell Carcinoma Summit Novel Agents and Clinical Controversies in Hereditary and Acquired RCC
Brought to you by:
Series Courses
Renal cell carcinoma (RCC), which can arise from genetic or acquired risk factors, is associated with significant morbidity and mortality. One of the most common genetic RCC syndromes, von Hippel-Lindau (VHL) has a 70% lifetime risk of RCC. Clinicians involved in treating patients with VHL or RCC need to understand the paradigms for current management, as well as emerging data on hereditary RCC and advanced or relapsed/refractory RCC.